Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Natco Pharma Ltd.
NSE: NATCOPHARM
|
BSE: 524816
|
ISIN: INE987B01026
|
Industry: Pharmaceuticals
|
Strong Performer, Getting Expensive
1185.0000
3.10
(
0.26
%)
NSE
May 13, 2026
10:01 AM
New 52W High in past week
Volume:
136.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Natco Pharma Ltd.
17 Nov 2022
1185.00
0.26%
Natco Pharma
Hold:
Natco Pharma Ltd.
by
ICICI Direct
Target: 660
Target
ICICI Direct
Number of FII/FPI investors increased from 254 to 285 in Mar 2026 qtr.
More from Natco Pharma Ltd.
Recommended
Market opens higher, Dr Reddy's Labs' Q4FY26 net profit plunges 86% YoY
Trendlyne Marketwatch |
13 May 2026, 09:43AM
Five stocks to buy from analysts this week - May 12, 2026
The Baseline |
12 May 2026, 05:09PM
Earnings Call Transcript - Q4FY20 for Natco Pharma
|
18 Jun 2020